Product Information

TRAVOPROST 0.004% EYE DROP is a generic product labeled by Apotex Corp., priced at $8.7821 per ML under NDC 60505059304. Its NADAC has been published 353 times since Feb 19, 2020.

FDA first approved this application on Jul 10, 2015. Its Orange Book therapeutic-equivalence code is AT2.

TRAVOPROST 0.004% EYE DROP

travoprost
$8.7821per ML

Strength

.04 mg/mL

Manufacturer

Apotex Corp.

NDC

60505059304

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

TRAVOPROST

Approval Type

Generic (ANDA)

FDA Application

ANDA203431

FDA Approved

7/10/2015

TE Code

AT2

On Market Since

12/18/2019

Pharmacological Classes

Prostaglandin Analog
Prostaglandins

Price Statistics

The NADAC for TRAVOPROST 0.004% EYE DROP has been published 353 times since Feb 19, 2020, and over the history we have for it it has declined 80.1%. The table below summarizes its recorded NADAC range and movement.

Current price$8.7821 per ML
All-time high$49.7487 (Apr 15, 2020)
All-time low$7.9822 (Jul 22, 2026)
52-week high$10.4525
52-week low$7.9822
Median price$21.2670
Average price$25.4615
Largest weekly change-25.2% (Apr 17, 2024)
Weeks tracked353
Tracking sinceFeb 19, 2020

Price History

1W

+0.9%

1M

+4.6%

3M

+6.3%

6M

+2.8%

1Y

-15.8%

3Y

-54.4%

5Y

-75.6%

All

-80.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 0%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRAVOPROST 0.004% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for TRAVOPROST 0.004% EYE DROP, manufactured by Apotex Corp., is $8.7821 per ML (NDC 60505059304), effective Nov 18, 2026.

How has the price of TRAVOPROST 0.004% EYE DROP changed over time?

Over the history we have for it, the NADAC for TRAVOPROST 0.004% EYE DROP has declined 80.1%. It has been tracked across 353 weekly CMS publications since Feb 19, 2020.

What are the highest and lowest recorded NADAC prices for TRAVOPROST 0.004% EYE DROP?

Since Feb 19, 2020, the NADAC for TRAVOPROST 0.004% EYE DROP has ranged from a low of $7.9822 (Jul 22, 2026) to a high of $49.7487 (Apr 15, 2020), with a median of $21.2670 per ML.

Are there cheaper alternatives to TRAVOPROST 0.004% EYE DROP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRAVOPROST 0.004% EYE DROP, is $8.7425 per ML — about 0% below TRAVOPROST 0.004% EYE DROP.

Who manufactures TRAVOPROST 0.004% EYE DROP?

TRAVOPROST 0.004% EYE DROP (NDC 60505059304) is labeled by Apotex Corp., and CMS classifies it as a generic product.